GLOBAL DIGITAL DIABETES MANAGEMENT MARKET SIZE TO CROSS USD 13 BILLION BY 2024, GROWING AT A CAGR OF 18% DURING THE FORECAST PERIOD

Digital Diabetes Management Market Size, Share, Trends, Analysis Report by Products (SMBG Meters, CGM Devices, Insulin Pumps, Digital Insulin Pens), Applications, and Software), Distribution Channels (Retail and Online Stores), End-Users (Individual, Hospitals, Specialty Diabetics Clinics, And Others), and Geography (North America, APAC, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Market Share & Forecast, 2019–2024

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

268 Pages

icon-table

86 Tables

icon-chart

120 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

52 Companies

icon-market

4 Market Segment

Digital Diabetes Management Market REPORT Scope

Report Attribute Details
Market Size (REVENUE) USD 13 BILLION (2024)
CAGR 18% (2019-2024)
Base Year 2018
Forecast Year 2019-2024
Market Segments Products (SMBG Meters, CGM Devices, Insulin Pumps, Digital Insulin Pens), Applications, and Software), Distribution Channels (Retail and Online Stores), End-Users (Individual, Hospitals, Specialty Diabetics Clinics, And Others)
Geographic Analysis North America, APAC, Europe, Latin America, and Middle East & Africa
Countries Covered US, Canada, Argentina, Australia, Brazil, China, France, Germany, India, Iran, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, Turkey, and UK

INDUSTRY INSIGHTS

The digital diabetes management market size will reach USD 13 billion by 2024, growing at a CAGR of 18% during 2019-2025. The market has witnessed significant growth in sales volume due to the growing prevalence of diabetes and the increasing awareness of self-management of the disease. The increased demand from developing regions, the introduction of innovative smart diabetes management devices, and increased marketing activities via online stores contribute to the growth of the market worldwide.

The market has been witnessing a broad range of technological innovations and improvements in recent years. As the demand for digitally advanced blood glucose monitoring devices is growing significantly, vendors are focusing on developing innovative devices, incorporating new technological platforms, and improving existing ones to enhance overall patient care. Besides, vendors are also offering a wide range of innovative BGM devices with improved features such as inbuilt alert systems, wireless connectivity, data storage, compatibility with Android and iOS platforms, and messaging options to evaluate the patient’s blood glucose levels regularly. Hence, the introduction of advanced digital devices has enabled both patients and healthcare professionals to monitor blood glucose levels in real-time, thereby enhancing the management of diabetes.

The digital diabetes management market is highly influenced by the increasing adoption of smartphones, wearable medical devices, and the availability of several mHealth applications for blood glucose tracking. mHealth applications and data integration software platforms help in storing blood glucose data of the patient and transmitting the same to healthcare professionals for clinical decision making. Therefore, the increasing usage of mobile applications and data management platforms contributes to the growing demand for smart devices for effective and accurate diabetic management. 

DIGITAL DIABETES MANAGEMENT MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Products
  • Distribution Channels
  • End-users
  • Geography

INSIGHTS BY PRODUCTS

The digital diabetes management devices segment is growing at a faster rate due to the growing adoption of several digitally advanced diabetic care devices, including digital blood glucose meters, Continuous Glucose Monitoring (CGM) devices, insulin pumps, and digital insulin pens. Among all these devices, CGM devices are contributing to the largest share in 2018. The wide availability of technologically advanced blood glucose monitoring devices and the rapid expansion of telehealthcare facilities contribute to the digital diabetes management market share.

The growing prevalence of diabetes, mainly in the growing geriatric population, is the key factor driving the growth of the applications and software segment. Further, technological advancements are a crucial factor in the development of the segment. The encouraging sale of smartphones, coupled with growing focus on home healthcare and remote patient monitoring, has led to several mHealth applications for tracking several health activities such as physical activities, blood glucose levels, blood pressure, heart rate, among others.

INSIGHTS BY DISTRIBUTION CHANNEL TYPE  

Retail stores are considered an indispensable distribution channel for digital diabetes monitoring devices. They offer easy access to a broad customer base and involve personalized attention to each consumer’s needs. A major exciting trend observed in this distribution system is that they are increasingly getting integrated with online platforms with retail chains either having their standalone online portals or participating through marketplaces through e-commerce companies.

Online stores have played a pivotal role in dispensing information and bringing radical changes in the consumption pattern and the shopping behavior of consumers. The rise of standalone web portals for retailers and the emergence of exclusive online marketplaces for home care and self-testing products such as digital BGM devices have recently gained attention in the market. For instance, BGM devices and accessories are readily available through online e-commerce portals such as Amazon, Flipkart, Snapdeal, and Paytm. Besides, manufacturers are also offering BGM devices through direct B2C online channels.

INSIGHTS BY END-USERS

The rapidly increasing diabetic population due to unhealthy lifestyle patterns, excess alcohol consumption, low diet, and the lack of physical activities worldwide are majorly contributing to the growing demand for several digital diabetes devices. Also, the healthcare industry has witnessed a paradigm shift in the last decade with an increasing preference toward self-monitoring of blood glucose levels over hospital-based testing.

Healthcare professionals in hospitals and clinics use professional devices for quick and accurate measurement of blood glucose levels. The hospital segment is growing at a healthy rate and is likely to grow steadily during the forecast period. The adoption of POC tests, which is increasing at a significant rate for evaluating blood glucose levels, is a major factor for digital diabetes management market growth. The availability of skilled healthcare professionals with knowledge and expertise in assessing blood glucose levels and aiding in diabetes management attracts more patients to hospitals and clinics than other healthcare providers.

INSIGHTS BY GEOGRAPHY

The growing diabetic patient population, high preference for self-monitoring of blood glucose levels, and the advent of highly advanced and innovative blood glucose management devices are the primary factors for the high share in North America. Also, the growing geriatric population with an increased risk of increasing blood glucose levels is another key factor driving the growth of the region.

Europe is the second-largest market. Germany, France, Spain, the UK, and Italy are the major revenue contributors in Europe. The growth is mainly due to the highly sophisticated healthcare infrastructure, the increasing patient population with high awareness levels regarding the availability of advanced treatment options for diabetic care.

APAC is the third-largest market. It has the largest population density and the highest proportion of people with diabetes. India and China population have around 195 million people with diabetes. Japan, China, South Korea, India, and Australia are the major revenue contributors from the region. China, South Korea, and India hold significant shares and are expected to witness the significant growth rate due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives for an increase in the healthcare access.

Brazil, Mexico, and Argentina are the major revenue contributors to the digital diabetes management market shares in Latin America. Turkey, Saudi Arabia, Iran, and South Africa are the major revenue contributors in MEA. The lack of awareness and the availability of various advanced treatment options for diabetic management have led to lower uptake in MEA than the US, Europe, Latin America, and APAC.

KEY VENDOR ANALYSIS

The global digital diabetes management market is highly competitive and dynamic, characterized by the presence of many international, regional, and local vendors offering a diverse range of technologically advanced devices, including CGM devices, test strips, digital insulin pens, insulin pumps sensors, lancets, and lancing devices for enhancing/improving the overall patient care. Approximately more than 400 vendors are offering such a wide array of products worldwide. Many global, regional, and local players manufacture and promote a diverse range of devices for the effective management of diabetes. The market is subject to rapid technological changes and significantly affected by new product launched and other strategies of industry participants Abbott, Ascensia Diabetes Care, B.  Braun Melsungen, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, and Insulet are the major players.

The digital diabetes management market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Products

  • Devices
  • Applications and Software

By Distribution Channel Type

  • Retail Stores
  • Online Channels

By End-users

  • Individuals
  • Hospitals and Specialty Diabetes Clinics
  • Others

By Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentine
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • Iran

Frequently Asked Questions

What is the digital diabetes management market size in 2019?

The digital diabetes management market size will reach USD 13 billion in 2024, growing at a CAGR of 18% during 2019-2024.

Which product/end-user/region is generating the largest revenue in the digital diabetes management market?

The digital diabetes management devices segment is growing at a faster rate due to the growing adoption of several digitally advanced diabetic care devices, including digital blood glucose meters, Continuous Glucose Monitoring (CGM) devices, insulin pumps, and digital insulin pens

What are the drivers, trends, and restraints influencing the growth of the European digital diabetes management market?

Europe is the second-largest market. Germany, France, Spain, the UK, and Italy are the major revenue contributors in Europe. The growth is mainly due to the highly sophisticated healthcare infrastructure, the increasing patient population with high awareness levels regarding the availability of advanced treatment options for diabetic care

Who are the leading vendors in the digital diabetes management market, and what are their market shares?

The leading vendors are Abbott, Ascensia Diabetes Care, B. Braun Melsungen, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, and Insulet.

Download Free Sample

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018–2024.

 The following factors are likely to contribute to the growth of the market during the forecast period:

  • Growing Prevalence of diabetes
  • Increasing Availability of mHealth applications
  • The emergence of Closed-loop/hybrid Insulin Pumps
  • Increasing Popularity of Connected/Smart Diabetes Management Devices

Base Year:                  2018

Forecast Year:           2019–2024

The study considers the present scenario of the digital diabetes management market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspects of the market. The report profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Ascenia Diabetes Care
    • Business Overview
    • Major Product Offerings
    • Product Portfolio
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Abbott
  • Braun Melsungen
  • Dexcom
  • Hoffmann-La Roche
  • Insulet
  • LifeScan
  • Medtronic

Other Prominent Vendors

  • 77 Elektronika
    • Business Overview
    • Major Product Offerings
  • Menarini Diagnostics
  • ACON Laboratories
  • AgaMatrix
  • Alliance International
  • Andon Health (Tianjin Jiu'an Medical Electronics)
  • Animas
  • ApexBio
  • ARKRAY
  • Beurer
  • Biocor
  • Bionime
  • Bioptik
  • BioTelemetry
  • Biotest Medical
  • BTNX
  • Care Innovations
  • Companion Medical
  • DarioHealth
  • Diabnext
  • DIAMESCO
  • Digital Medics
  • Emperra
  • GlucoMe
  • Integrity Applications
  • Jiangsu Delfu Medical Device
  • Medisana
  • Medtrum Technologies
  • Nova Biomedical
  • Novo Nordisk
  • Omnis Health
  • One Drop
  • Philosys
  • Prodigy Diabetes Care
  • Sanofi
  • Senseonics Holdings
  • SOOIL Developments
  • Taidoc Technology
  • Terumo
  • Trividia Health
  • Rossmax International
  • Tandem Diabetes Care
  • Patients Pending
  • Ypsomed Trinity Biotech

Market Segmentation by Products

  • Digital Diabetes Management Devices
  • Digital Diabetes Management Applications and Software

Market Segmentation by Distribution Channel Type

  • Retail Stores
  • Online Channels

Market Segmentation by End-users

  • Individuals
  • Hospitals and Specialty diabetes Clinics
  • Others

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentine
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa
    • Iran

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Products

4.4.2 Market Segmentation by Distribution Channels

4.4.3 Market Segmentation By End-user Type

4.4.4 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Diabetes: An Overview

7.1.1 Background

7.1.2 Digital Diabetes Management

7.1.3 Global Digital Diabetes Management: Market Snapshot

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Growing Prevalence of Diabetes

8.1.2 Growing Technological Advancements in Digital Diabetes Management

8.1.3 Increasing Availability of Mobile Applications

8.1.4 New Product Approvals/Launches

8.2 Market Growth Restraints

8.2.1 High Cost of Digital Diabetes Management Devices

8.2.2 Presence of Large Pool of Undiagnosed Population

8.2.3 Threat from Conventional Diabetes Management Devices

8.3 Market Opportunities & Trends

8.3.1 Emergence of Closed Loop/Hybrid Insulin Pumps

8.3.2 Growing Demand for Smart Insulin Pens

8.3.3 Rising Popularity of Connected/Smart Diabetes Management Devices

8.3.4 Promising Investigational Digital Diabetes Management Devices

9 Global Digital Diabetes Management Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Digital Diabetes Management Market by Product Type

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

11 Digital Diabetes Management Devices

11.1 Market Overview

11.1.1 Market Size & Forecast

11.2 Segmentation by Product Type

11.2.1 Market Snapshot & Growth Engine

11.3 CGM Devices

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Insulin Pumps

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 Digital Blood Glucose Meters

11.5.1 Market Overview

11.5.2 Market Size & Forecast

11.6 Digital Insulin Pens

11.6.1 Market Overview

11.6.2 Market Size & Forecast

12 Digital Diabetes Management Apps & Software

12.1 Market Overview

12.1.1 Market Size & Forecast

13 Digital Diabetes Management Market by Distribution Channels

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Offline Retail Channels

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Online Channels

13.4.1 Market Overview

13.4.2 Market Size & Forecast

14 Digital Diabetes Management Market by End-Users

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Individuals

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 Hospitals & Specialty Diabetes Clinics

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 Other End-users

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 Digital Diabetes Management Market by Geography

15.1 Market Snapshot & Growth Engine

15.2 Overview

16 North America

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 US: Market Size & Forecast

16.3.2 Canada: Market Size & Forecast

17 Europe

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 Germany: Market Size & Forecast

17.3.2 France: Market Size & Forecast

17.3.3 Spain: Market Size & Forecast

17.3.4 UK: Market Size & Forecast

17.3.5 Italy: Market Size & Forecast

18 APAC

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 China: Market Size & Forecast

18.3.2 Japan: Market Size & Forecast

18.3.3 South Korea: Market Size & Forecast

18.3.4 India: Market Size & Forecast

18.3.5 Australia: Market Size & Forecast

19 Latin America

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Brazil: Market Size & Forecast

19.3.2 Mexico: Market Size & Forecast

19.3.3 Argentina: Market Size & Forecast

20 Middle East & Africa

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Key Countries

20.3.1 Turkey: Market Size & Forecast

20.3.2 Saudi Arabia: Market Size & Forecast

20.3.3 Iran: Market Size & Forecast

20.3.4 South Africa: Market Size & Forecast

21 Competitive Landscape

21.1 Competition Overview

21.2 Market Share Analysis

21.2.1 Digital Blood Glucose Meters

21.2.2 CGM Devices

21.2.3 Digital Insulin Pens

21.2.4 Insulin Pumps

22 Key Vendors

22.1 Ascensia Diabetes Care

22.1.1 Business Overview

22.1.2 Major Product Offerings

22.1.3 Key Strategies

22.1.4 Key Strengths

22.1.5 Key Opportunities

22.2 Abbott

22.2.1 Business Overview

22.2.2 Abbott in Global Digital Diabetes Management Market

22.2.3 Major Product Offerings

22.2.4 Key Strategies

22.2.5 Key Strengths

22.2.6 Key Opportunities

22.3 B. Braun Melsungen

22.3.1 Business Overview

22.3.2 B. Braun Melsungen in Global Digital Diabetes Management Market

22.3.3 Major Product Offerings

22.3.4 Key Strategies

22.3.5 Key Strengths

22.3.6 Key Opportunities

22.4 Dexcom

22.4.1 Business Overview

22.4.2 Dexcom in Global Digital Diabetes Management Market

22.4.3 Major Product Offerings

22.4.4 Key Strategies

22.4.5 Key Strengths

22.4.6 Key Opportunities

22.5 F. Hoffmann-La Roche

22.5.1 Business Overview

22.5.2 F. Hoffmann-La Roche in The Global Digital Diabetes Management Market

22.5.3 Major Product Offerings

22.5.4 Key Strategies

22.5.5 Key Strengths

22.5.6 Key Opportunities

22.6 LifeScan

22.6.1 Business Overview

22.6.2 LifeScan in Global Digital Diabetes Management Market

22.6.3 Major Product Offerings

22.6.4 Key Strategies

22.6.5 Key Strengths

22.6.6 Key Opportunities

22.7 Medtronic

22.7.1 Business Overview

22.7.2 Medtronic in Global Digital Diabetes Management Market

22.7.3 Major Product Offerings

22.7.4 Key Strategies

22.7.5 Key Strengths

22.7.6 Key opportunities

22.8 Insulet

22.8.1 Business Overview

22.8.2 Insulet in Global Digital Diabetes Management Market

22.8.3 Major Product Offerings

22.8.4 Key Strategies

22.8.5 Key Strengths

22.8.6 Key Opportunities

23 Other Prominent Vendors

23.1 77 ELEKTRONIKA

23.1.1 Business Overview

23.1.2 Major Product Offerings

23.2 A. Menarini Diagnostics

23.2.1 Business Overview

23.2.2 Major Product Offerings

23.3 ACON Laboratories

23.3.1 Business Overview

23.3.2 Major Product Offerings

23.4 Agamatrix

23.4.1 Business Overview

23.4.2 Major Product Offerings

23.5 Alliance International

23.5.1 Business Overview

23.5.2 Major Product Offerings

23.6 Andon Health (Tianjin Jiu'an Medical Electronics)

23.6.1 Business Overview

23.6.2 Major Product Offerings

23.7 Animas

23.7.1 Business Overview

23.7.2 Major Product Offerings

23.8 ApexBio

23.8.1 Business Overview

23.8.2 Major Product Offerings

23.9 Arkray

23.9.1 Business Overview

23.9.2 Major Product Offerings

23.1 Beurer

23.10.1 Business Overview

23.10.2 Major Product Offerings

23.11 Biocorp

23.11.1 Business Overview

23.11.2 Major Product Offerings

23.12 Bionime

23.12.1 Business Overview

23.12.2 Major Product Offerings

23.13 Bioptik

23.13.1 Business Overview

23.13.2 Major Product Offerings

23.14 BioTelemetry

23.14.1 Business Overview

23.14.2 Major Product Offerings

23.15 Biotest Medical

23.15.1 Business Overview

23.15.2 Major Product Offerings

23.16 BTNX

23.16.1 Business Overview

23.16.2 Major Product Offerings

23.17 Care Innovations

23.17.1 Business Overview

23.17.2 Major Product Offerings

23.18 Companion Medical

23.18.1 Business Overview

23.18.2 Major Product Offerings

23.19 DarioHealth

23.19.1 Business Overview

23.19.2 Major Product Offerings

23.20 Diabnext

23.20.1 Business Overview

23.20.2 Major Product Offerings

23.21 DIAMESCO

23.21.1 Business Overview

23.21.2 Major Product Offerings

23.22 Digital Medics

23.22.1 Business Overview

23.22.2 Major Product Offerings

23.23 Emperra

23.23.1 Business Overview

23.23.2 Major Product Offerings

23.24 GlucoMe

23.24.1 Business Overview

23.24.2 Major Product Offerings

23.25 Integrity Applications

23.25.1 Business Overview

23.25.2 Major Product Offerings

23.26 Jiangsu Delfu medical device

23.26.1 Business Overview

23.26.2 Major Product Offerings

23.27 Medisana

23.27.1 Business Overview

23.27.2 Major Product Offerings

23.28 Medtrum Technologies

23.28.1 Business Overview

23.28.2 Major Product Offerings

23.29 Nova Biomedical

23.29.1 Business Overview

23.29.2 Major Product Offerings

23.30 Novo Nordisk

23.30.1 Business Overview

23.30.2 Major Product Offerings

23.31 Omnis Health

23.31.1 Business Overview

23.31.2 Major Product Offerings

23.32 One Drop

23.32.1 Business Overview

23.32.2 Major Product Offerings

23.33 Philosys

23.33.1 Business Overview

23.33.2 Major Product Offerings

23.34 Prodigy Diabetes Care

23.34.1 Business Overview

23.34.2 Major Product Offerings

23.35 Sanofi

23.35.1 Business Overview

23.35.2 Major Product Offerings

23.36 Senseonics Holdings

23.36.1 Business Overview

23.36.2 Major Product Offerings

23.37 SOOIL Developments

23.37.1 Business Overview

23.37.2 Major Product Offerings

23.38 Taidoc Technology

23.38.1 Business Overview

23.38.2 Major Product Offerings

23.39 Terumo

23.39.1 Business Overview

23.39.2 Major Product Offerings

23.40 Trividia Health

23.40.1 Business Overview

23.40.2 Major Product Offerings

23.41 Rossmax International

23.41.1 Business Overview

23.41.2 Major Product Offerings

23.42 Tandem Diabetes Care

23.42.1 Business Overview

23.42.2 Major Product Offerings

23.43 Patients Pending

23.43.1 Business Overview

23.43.2 Major Product Offerings

23.44 Ypsomed

23.44.1 Business Overview

23.44.2 Major Product Offerings

24 Report Summary

24.1 Key Takeaways

24.2 Strategic Recommendations

24.3 Quantitative Summary

24.3.1 By Product

24.3.2 By Distribution Channel

24.3.3 By End-user

24.3.4 By Geography

24.3.5 Digital Diabetes Management Devices

25 Appendix

25.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Digital Diabetes Management Market

Exhibit 2               Market Size Calculation Approach 2018

Exhibit 3               Blood Glucose Level Range & Associated Risk Factors

Exhibit 4               Growing Prevalence of Diabetes

Exhibit 5               Global Diabetes Prevalence 2017−2045 (%)

Exhibit 6               Global Prevalence of Diabetes in Females by Age Group 2017 (%)

Exhibit 7               Global Prevalence of Diabetes in Males by Age Group 2017 (%)

Exhibit 8               Growing Technological Advancements in Digital Diabetes Management

Exhibit 9               Increasing Availability of Mobile Applications

Exhibit 10             New Product Approvals/Launches

Exhibit 11             High Cost of Digital Diabetes Management Devices

Exhibit 12             Global Diabetes-related Expenditure by Regions 2017 ($ billion)

Exhibit 13             Presence of Large Pool of Undiagnosed Population

Exhibit 14             Global Undiagnosed Diabetes Population (20–79 Years by Regions 2017 (%))

Exhibit 15             Threat from Conventional Diabetes Management Devices

Exhibit 16             Challenges to Adoption of Diabetes Management Devices vs. Conventional Devices

Exhibit 17             Emergence of Closed Loop/Hybrid Insulin Pumps

Exhibit 18             Growing Demand for Smart Insulin Pens

Exhibit 19             Rising Popularity of Connected/Smart Diabetes Management Devices

Exhibit 20             Promising Investigational Digital Diabetes Management Devices

Exhibit 21             Importance of Blood Glucose Monitoring in Diabetes Management

Exhibit 22             Global Digital Diabetes Management Market 2018−2024 ($ million)

Exhibit 23             Global Market by Geography

Exhibit 24             Global Market by Product Type

Exhibit 25             Global Market by Distribution Channels

Exhibit 26             Global Market by End-users

Exhibit 27             Five Forces Analysis 2018

Exhibit 28             Incremental Growth by Product Type 2018−2024

Exhibit 29             Global Digital Diabetes Management Market by Product Type

Exhibit 30             Global Market by Product Type: Incremental Growth

Exhibit 31             Global Market by Product Type: Absolute Growth

Exhibit 32             Global Market by Product Type 2018 & 2024 (%)

Exhibit 33             Global Market by Product Type 2018−2024 ($ million)

Exhibit 34             Digital Diabetes Management Devices: Incremental Growth

Exhibit 35             Digital Diabetes Management Devices: Absolute Growth

Exhibit 36             Digital Diabetes Management Devices 2018 & 2024 (%)

Exhibit 37             Digital Diabetes Management Devices 2018−2024 ($ million)

Exhibit 38             Digital Diabetes Management Devices 2018−2024 (%)

Exhibit 39             Global Digital Diabetes Management Devices Market 2018−2024 ($ million)

Exhibit 40             Incremental Growth by Product Type 2018−2024

Exhibit 41             Global CGM Devices Market 2018−2024 ($ million)

Exhibit 42             Global Insulin Pumps Market 2018−2024 ($ million)

Exhibit 43             Global Digital Diabetes Meters Market 2018−2024 ($ million)

Exhibit 44             Global Digital Insulin Pens Market 2018−2024 ($ million)

Exhibit 45             Global Digital Diabetes Apps & Software Market 2018−2024 ($ million)

Exhibit 46             Incremental Growth by Distribution Channels

Exhibit 47             Global Digital Diabetes Management Market by Distribution Channels 2018 & 2024 (%)

Exhibit 48             Global Market by Distribution Channels 2018−2024 ($ million)

Exhibit 49             Digital Market by Distribution Channels 2018− 2024 (%)

Exhibit 50             Global Market by Distribution Channels

Exhibit 51             Global Market by Distribution Channels: Absolute Growth

Exhibit 52             Global Offline Digital Diabetes Management Market 2018−2024 ($ million)

Exhibit 53             Global Online Digital Diabetes Management Market 2018−2024 ($ million)

Exhibit 54             Incremental Growth by End-users Type

Exhibit 55             Global Digital Diabetes Management Market by End-users 2018−2024 ($ million)

Exhibit 56             Global Market by End-users 2018−2024 (%)

Exhibit 57             Global Market by End-users

Exhibit 58             Global Individual Digital Diabetes Management Market 2018−2024 ($ million)

Exhibit 59             Global Hospitals & Specialty Diabetes Clinics Market 2018−2024 ($ million)

Exhibit 60             Global Other Digital Diabetes Management Market 2018−2024 ($ million)

Exhibit 61             Incremental Growth by Geography 2018−2024

Exhibit 62             Global Digital Diabetes Management Market by Geography

Exhibit 63             Global Market by Geography 2018−2024 ($ million)

Exhibit 64             Diabetes Prevalence Rate among Females in North America by Age Group 2017 (%)

Exhibit 65             Diabetes Prevalence Rate among Males in North America by Age Group 2017 (%)

Exhibit 66             North America Diabetes Statistics by Country 2017 (%)

Exhibit 67             Market in North America 2018−2024 ($ million)

Exhibit 68             Incremental Growth in North America 2018−2024

Exhibit 69             Market in US 2018−2024 ($ million)

Exhibit 70             Market in Canada 2018−2024 ($ million)

Exhibit 71             Diabetes Prevalence Rate among Females in Europe by Age Group 2017 (%)

Exhibit 72             Diabetes Prevalence Rate Among Males in Europe by Age Group 2017 (%)

Exhibit 73             Market in Europe 2018–2024 ($ million)

Exhibit 74             Incremental Growth in Europe 2018−2024

Exhibit 75             Market in Germany 2018–2024 ($ million)

Exhibit 76             Market in France 2018–2024 ($ million)

Exhibit 77             Market in Spain 2018–2024 ($ million)

Exhibit 78             Market in UK 2018–2024 ($ million)

Exhibit 79             Market in Italy 2018–2024 ($ million)

Exhibit 80             Market in APAC 2018−2024 ($ million)

Exhibit 81             Incremental Growth in APAC 2018−2024

Exhibit 82             Market in China 2018−2024 ($ million)

Exhibit 83             Market in Japan 2018−2024 ($ million)

Exhibit 84             Market in South Korea 2018−2024 ($ million)

Exhibit 85             Market in India 2018−2024 ($ million)

Exhibit 86             Prevalence of Self-Reported Diabetes in People Aged 18 and Over, by Age and Sex, 2017–2018 (%)

Exhibit 87             Market in Australia 2018−2024 ($ million)

Exhibit 88             Diabetes Prevalence Rate among Females in Latin America by Age Group 2017 (%)

Exhibit 89             Diabetes Prevalence Rate Among Females in Latin America by Age Group 2017 (%)

Exhibit 90             Market in LATAM 2018−2024 ($ million)

Exhibit 91             Incremental Growth in Latin America 2018−2024

Exhibit 92             Market in Brazil 2018−2024 ($ million)

Exhibit 93             Market in Mexico 2018−2024 ($ million)

Exhibit 94             Number of Diabetes Deaths in Different Age Groups by Gender 2016

Exhibit 95             Market in Argentina 2018−2024 ($ million)

Exhibit 96             Diabetes Prevalence Rate in Females in MEA by Age Group 2017 (%)

Exhibit 97             Diabetes Prevalence Rate in Males in MEA by Age Group 2017 (%)

Exhibit 98             Market in MEA 2018−2024 ($ million)

Exhibit 99             Incremental Growth in MEA 2018−2024

Exhibit 100          Market in Turkey 2018−2024 ($ million)

Exhibit 101          Market in Saudi Arabia 2018−2024 ($ million)

Exhibit 102          Market in Iran 2018−2024 ($ million)

Exhibit 103          Market in South Africa 2018−2024 ($ million)

Exhibit 104          Global CGM Devices Market: Key Vendors Market Share

Exhibit 105          Global Insulin Pumps Market: Key Vendors Market Share

Exhibit 106          Abbott: R&D Expenditure 2016−2018 ($ million)

Exhibit 107          Abbott: Sales Breakdown by Segments 2017−2018 ($ million)

Exhibit 108          Abbott Sales Breakdown by Geography 2018 (%)

Exhibit 109          B. Braun Melsungen R&D Expenditure 2016−2018 ($ million)

Exhibit 110          B. Braun Melsungen Revenue by Division 2017−2018 ($ million)

Exhibit 111          B. Braun Melsungen Sales by Region 2018 (%)

Exhibit 112          Dexcom: R&D Expenditure 2016−2018 ($ million)

Exhibit 113          Dexcom: Revenue by Geography 2018 (%)

Exhibit 114          F. Hoffmann-La Roche R&D Expenditure 2016−2018 ($ billion)

Exhibit 115          F. Hoffmann-La Roche Revenue by Business Segments 2017−2018 ($ billion)

Exhibit 116          F. Hoffmann-La Roche Revenue by Geography 2018 (%)

Exhibit 117          Medtronic: Revenue by Business Segments 2017−2018 ($ million)

Exhibit 118          Medtronic: Revenue Breakdown by Geography FY2018 (%)

Exhibit 119          Insulet: R&D Expenditure 2016−2018 ($ million)

Exhibit 120          Insulet: Revenue by Divisions 2017−2018 ($ million)

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2018

Table 3                  Standard Range of Blood Sugar Levels

Table 4                  Few Latest-generation Blood Glucose Monitoring Devices Available in Market

Table 5                  Common Features in mHealth Diabetes Management Applications in Addition to BGM

Table 6                  Key Mobile Applications and Data Integration Platforms for Diabetes Management

Table 7                  Recent Product Approvals & Launches in Global Digital Diabetes Management Market

Table 8                  Leading Countries with Highest Undiagnosed Diabetes Population 2017

Table 9                  Emerging Next-generation Closed-loop Insulin Delivery Systems

Table 10               Connected/Smart Diabetes Management Devices Available in the Market

Table 11               Global Digital Diabetes Management Devices Market: Pipeline Devices

Table 12               Commercially Available CGM Devices by Significant Market Players

Table 13               Significant Players Offering Insulin Pumps

Table 14               Few Significant Players Offering Advanced BGM Devices

Table 15               Significant Players Offering Insulin Pens

Table 16               Several Diabetes Management Platforms & Software Available in the Market

Table 17               Countries with Highest Diabetic Population in Europe 2017

Table 18               Countries with Highest Diabetes Population in APAC 2017

Table 19               Countries with Highest Diabetes Population in Latin America 2017

Table 20               Leading Countries with Diabetes Population in MEA 2017

Table 21               Global Digital Blood Glucose Meters Market: Top Vendors Ranking

Table 22               Global CGM Devices Market: Top Vendors Ranking

Table 23               Global Insulin Pumps Market: Top Vendors Ranking

Table 24               Ascensia Diabetes Care: Key Product Offerings

Table 25               Abbott: Key Product Offerings

Table 26               B. Braun Melsungen’s Therapy Fields & Applications

Table 27               B. Braun Melsungen: Key Product Offerings

Table 28               Dexcom: Key Product Offerings

Table 29               F. Hoffmann-La Roche: Key Product Offerings

Table 30               LifeScan: Key Product Offerings

Table 31               Medtronic: Key Product Offerings

Table 32               Insulet: Key Product Offerings

Table 33               77 ELEKTRONIKA: Key Product Offerings

Table 34               A. Menarini Diagnostics: Key Product Offerings

Table 35               ACON Laboratories: Key Product Offerings

Table 36               AgaMatrix: Key Product Offerings

Table 37               Alliance International: Key Product Offerings

Table 38               ANDON HEALTH (TIANJIN JIU'AN MEDICAL ELECTRONICS): Key Product Offerings

Table 39               Animas: Key Product Offerings

Table 40               ApexBio: Key Product Offerings

Table 41               ARKRAY: Key Product Offerings

Table 42               BEURER: Key Product Offerings

Table 43               BIOCORP: Key Product Offerings

Table 44               Bionime: Key Product Offerings

Table 45               Bioptik: Key Product Offerings

Table 46               BioTelemetry: Key Product Offerings

Table 47               BIOTEST MEDICAL: Key Product Offerings

Table 48               BTNX: Key Product Offerings

Table 49               Care Innovations: Key Product Offerings

Table 50               Companion Medical: Key Product Offerings

Table 51               DarioHealth: Key Product Offerings

Table 52               Diabnext: Key Product Offerings

Table 53               DIAMESCO: Key Product Offerings

Table 54               Digital Medics: Key Product Offerings

Table 55               Emperra: Key Product Offerings

Table 56               GlucoMe: Key Product Offerings

Table 57               Integrity Applications: Key Product Offerings

Table 58               Jiangsu Delfu medical device: Key Product Offerings

Table 59               Medisana: Key Product Offerings

Table 60               Medtrum Technologies: Key Product Offerings

Table 61               Nova Biomedical: Key Product Offerings

Table 62               Novo Nordisk: Key Product Offerings

Table 63               Omnis Health: Key Product Offerings

Table 64               One Drop: Key Product Offerings

Table 65               Philosys: Key Product Offerings

Table 66               Prodigy Diabetes Care: Key Product Offerings

Table 67               Sanofi: Key Product Offerings

Table 68               Senseonics Holdings: Key Product Offerings

Table 69               SOOIL Developments: Key Product Offerings

Table 70               Taidoc Technology: Key Product Offerings

Table 71               Terumo: Key Product Offerings

Table 72               Trividia Health: Key Product Offerings

Table 73               Rossmax International: Key Product Offerings

Table 74               Tandem Diabetes Care: Key Product Offerings

Table 75               Patients Pending: Key Product Offerings

Table 76               Ypsomed: Key Product Offerings

Table 77               Global Digital Diabetes Management Market by Products ($ million)

Table 78               Global Market by Products (%)

Table 79               Global Digital Diabetes Management Market by Distribution Channels ($ million)

Table 80               Global Market by Distribution Channels (%)

Table 81               Global Digital Diabetes Management Market by End-users ($ million)

Table 82               Global Market by End-users (%)

Table 83               Global Digital Diabetes Management Market by Geography ($ million)

Table 84               Global Digital Diabetes Management Devices Market by Geography (%)

Table 85               Global Digital Diabetes Management Devices Market ($ million)

Table 86               Global Digital Diabetes Management Devices Market (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date